Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Lactam. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108586517B details a cost-effective route for 4-AA using chiral resolution, offering reliable supply and reduced heavy metal contamination for API manufacturers.
Patent CN103570600B reveals Pd-catalyzed asymmetric amination for chiral beta-lactams. Enables cost reduction in pharmaceutical manufacturing with high enantioselectivity.
Discover advanced Pd-catalyzed synthesis for chiral beta-lactams. High enantioselectivity and scalable processes for reliable pharmaceutical intermediates supply chains.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel patent CN102285947B details high-purity Cabazitaxel synthesis. Offers supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN110872260B details a Pd-catalyzed asymmetric hydrogenation route for chiral lactams, offering high ee and yield for pharmaceutical intermediates.
Patent CN107488138B details a high-yield dithiolane-protected route for ezetimibe intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Novel synthetic method for penem antibiotic intermediate 4AA using L-threonine. High purity 99.34%, scalable process, cost-effective manufacturing solution.
Patent CN102603591B details a novel route for Vernakalant intermediates. Offers mild conditions, high optical purity, and scalable supply chain solutions for global procurement.
Novel patent CN104788357B details cost-effective chiral amino lactam synthesis offering supply chain stability and reduced manufacturing complexity for global partners.
Patent CN111793017A details a safe ruthenium-catalyzed transfer hydrogenation method for high-ee lactams, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN111925356A discloses stable chiral ligands enabling high-yield nickel-catalyzed lactam synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115490626B reveals a high-purity chiral intermediate route for PF-07321332. This method offers significant cost reduction and supply chain reliability for antiviral manufacturing.